slides · global inventory
11 Golden Circle
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,983
Current window 10,141-10,170
Pages 467
Rows per page 30
Loop
10,141-10,170 of 13,983
05
The central diagram is a circular quadrant model representing the company's ecosystem.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
Includes a map of global locations, a list of key business metrics, and two charts showing revenue breakdown.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
07
The slide uses a donut chart to segment publications by application and a list of value propositions to explain customer adoption.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
08
The central diagram is a circular process flow around a human figure, connecting specific clinical applications to the instruments used for them.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Loop · Golden Circle1 hit
09
The slide features a screenshot of an FDA news release and microscopic images of normal vs. sickle cells, alongside the Cytek ImageStream instrument.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Loop · Golden Circle1 hit
10
The slide uses a four-column process-like layout to describe strategic focus areas.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Beat · Business ModelLoop · Golden Circle1 hit
11
The slide uses a process-like flow to show how specific functionalities (Panel Design, Experimental Design, etc.) are integrated into a cloud-based solution.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Loop · Golden Circle1 hit
12
The slide uses a visual bridge connecting the hardware (NL-3000) to a list of value propositions.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Loop · Golden Circle1 hit
13
The central graphic is the Cytek logo, used as a hub for the strategic goals.Cytek | Investor Conference Presentation Deck | 16 slides · Cytek
Conference presentation Investor relations Beat · The AskLoop · Golden Circle1 hit
02
ESG Fact Sheet page 2Hyzon | ESG Presentation Deck | 4 slides · Hyzon
Shareholder letter Investor relations Beat · What Could BeLoop · Golden Circle1 hit
05
Includes a world map background with regional revenue/employee distribution bar and list of office locations.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide uses a central circle to unify the two business segments under a shared brand value proposition.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The central diagram is a pyramid structure representing Intellectual Capital as the foundation of the four pillars.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a 3x3 grid layout to categorize technological capabilities.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a 2x3 grid layout with a central horizontal banner emphasizing financial performance.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
This is a transition or thesis slide emphasizing competitive differentiation.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
04
NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slidesNeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slidesNeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · ProblemLoop · Golden Circle1 hit
06
The slide uses a Gantt-style layout to map clinical phases to specific time periods.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Loop · Golden Circle1 hit
07
The slide uses a medical illustration of the liver to highlight the target organ.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a standard comparison table format to contrast a competitor (Resmetirom) with the company's own asset (DA-1241).NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
09
The diagram shows a biological pathway from steatosis to steatohepatitis to fibrosis, highlighting the role of GPR119 activation in modulating cellular responses.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
10
The slide shows two heatmaps (17 inflammation genes, 22 stellate cell activation genes) and a biological pathway diagram.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
Includes specific study references and definitions for abbreviations like GPR119, MASH, and GLP-1.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
The slide presents 10 distinct bar charts comparing Control, DA, DA+DPP4i, and DPP4i groups, with statistical significance markers.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Includes study design details for a multicenter, randomized, double-blind, placebo-controlled trial.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a diagram to map the drug's mechanism of action to specific biological effects in the liver, pancreas, and immune system.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slidesNeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
16
The table highlights DA-1726's dual agonist mechanism (GLP-1R/GCGR) as a key differentiator against standard GLP-1 agonists.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
17
The slide uses a hub-and-spoke diagram to illustrate the systemic effects of the hormone.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit